Dr. MacLean Hall Earns the JITC Paper Award 2024

Dr. MacLean Hall, a Moffitt/USF Immunology and Immunotherapy PhD graduate from the Dr. Shari Pilon-Thomas lab, published a paper entitled, "Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients." His paper has been selected the Journal for ImmunoTherapy of Cancer (JITC) Best Immune Cell Therapies and Immune Cell Engineering Paper Award of the year!

Each year, the Society of Immunotherapy of Cancer (SITC) selects one article in the Immune Cell Therapies and Immune Cell Engineering category for presenting outstanding research on new targets, approaches, novel functionalities or engineering strategies, clinical trial results, correlative studies, gene-edited cells, or synthetic gene circuits to earn JITC Best Immune Cell Therapies and Immune Cell Engineering Paper Award.

Join us in congratulating Dr. Hall's incredible achievement!